Patent ID: 8101661

Claim:
A composition for treating a human or animal patient having attention deficit disorder or attention deficit hyperactivity disorder, comprising at least one salt of a conjugate comprising amphetamine chemically attached to homoarginine, wherein the salt is selected from an acefyllinate, 4-acetamidobenzoate, acetate, aceturate, adipate, aminosalicylate, ammonium, ascorbate, l-aspartate, besylate, bicarbonate, borate, butyrate, calcium, camphocarbonate, camphorate, d-camsylate, l-camsylate, camsylate, carbonate, cholate, cypionate, decanoate, dichloroacetate, edentate, edisylate, estolate, esylate, ethyl sulfate, fumarate, furate, fusidate, galactarate (mucate), galacturonate, gallate, gentisate, gluceptate, gluconate, glucuronate, glutamate, glutarate, glycerophosphate, glycolate, heptanoate (enanthate), hexanoate, hippurate, hybenzate, hydrobromide/bromide, hydroxide, hydroxybenzoate, iodide, isethionate, d-lactate, l-lactate, d,l-lactate, lactobionate, laurate, lithium, magnesium, maleate, malonate, mandelate, meso-tartrate, methanesulfonate, methylsulfate, myristate, napadisilate, 2-napsylate, nicotinate, octanoate, oleate, orotate, palmitate, pamoate, phenylpropionate, picrate, pivalate, potassium, propionate, pyrophosphate, salicylate, salicylsulfate, sodium, stearate, succinate, sulfosalicylate, tannate, terephthalate, thiocyanate, thiosalicylate, tosylate, tribrophenate, undecylenate, valerate, valproate, xinafoate, zinc, and mixtures thereof.